ArticlePloS one2026

EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFR.

Anne Pettikiriarachchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.